当前位置:首页 - 行情中心 - 雪榕生物(300511) - 财务分析 - 现金流量表

雪榕生物

(300511)

  

流通市值:23.41亿  总市值:26.34亿
流通股本:5.70亿   总股本:6.41亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,693,361,632.721,153,807,319.77676,114,712.661,962,574,102.43
  收到的税费返还679.62679.62--
  收到其他与经营活动有关的现金27,847,292.7823,114,591.1615,105,000.7119,836,012.61
  经营活动现金流入小计1,721,209,605.121,176,922,590.55691,219,713.371,982,410,115.04
  购买商品、接受劳务支付的现金991,879,025.72668,819,794.54347,816,267.141,069,149,863.24
  支付给职工以及为职工支付的现金372,541,644.98239,506,630.02115,258,867.38408,888,878.2
  支付的各项税费16,794,275.9812,061,472.135,838,883.8724,753,180.1
  支付其他与经营活动有关的现金53,819,144.3735,549,025.4618,704,229.3463,770,066.85
  经营活动现金流出小计1,435,034,091.05955,936,922.15487,618,247.731,566,561,988.39
  经营活动产生的现金流量净额286,175,514.07220,985,668.4203,601,465.64415,848,126.65
二、投资活动产生的现金流量:
  收回投资收到的现金3,279,950.423,279,950.42-4,600,000
  取得投资收益收到的现金265,721.44247,748.06--
  处置固定资产、无形资产和其他长期资产收回的现金净额2,972,796.721,656,146.73654,697.3425,588,465.48
  收到的其他与投资活动有关的现金20,000,000---
  投资活动现金流入小计26,518,468.585,183,845.21654,697.3430,188,465.48
  购建固定资产、无形资产和其他长期资产支付的现金221,603,111.53139,708,244.1672,568,778.6779,587,860.55
  支付其他与投资活动有关的现金20,000,000---
  投资活动现金流出小计241,603,111.53139,708,244.1672,568,778.6779,587,860.55
  投资活动产生的现金流量净额-215,084,642.95-134,524,398.95-71,914,081.33-49,399,395.07
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,100,0001,300,0001,000,000700,000
  其中:子公司吸收少数股东投资收到的现金2,100,0001,300,0001,000,000700,000
  取得借款收到的现金433,812,671.05243,050,000160,050,000453,813,392.08
  收到其他与筹资活动有关的现金72,661,434.4468,600,000-102,485,991.1
  筹资活动现金流入小计508,574,105.49312,950,000161,050,000556,999,383.18
  偿还债务支付的现金483,415,172.14280,536,676.31114,004,274.12779,469,044.75
  分配股利、利润或偿付利息支付的现金23,675,560.5916,572,761.657,929,749.4142,678,550.2
  支付其他与筹资活动有关的现金115,280,932.73105,498,514.3942,199,866.6792,362,201.65
  筹资活动现金流出小计622,371,665.46402,607,952.35164,133,890.2914,509,796.6
  筹资活动产生的现金流量净额-113,797,559.97-89,657,952.35-3,083,890.2-357,510,413.42
四、汇率变动对现金及现金等价物的影响-1,493,862.39-314,558.17-1,074,410.07259,737.37
五、现金及现金等价物净增加额-44,200,551.24-3,511,241.07127,529,084.049,198,055.53
  加:期初现金及现金等价物余额159,139,572.15159,139,572.15159,139,572.15149,941,516.62
  期末现金及现金等价物余额114,939,020.91155,628,331.08286,668,656.19159,139,572.15
补充资料:
  净利润-13,725,364.97-38,418,736.45
  资产减值准备-70,916,176.13-16,982,953.22
  固定资产和投资性房地产折旧-163,003,927.89-327,920,341.21
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-163,003,927.89-327,920,341.21
  无形资产摊销-4,572,814.41-8,710,482.78
  长期待摊费用摊销-1,691,399.15-2,902,819.36
  处置固定资产、无形资产和其他长期资产的损失-2,074,510.1--16,311,304.25
  固定资产报废损失-226,253.35-1,227,784.72
  公允价值变动损失----38,348.96
  财务费用-29,035,374.95-60,605,468.47
  投资损失--961,913.61--1,013,061.49
  存货的减少--54,499,431.03--61,423,165.92
  经营性应收项目的减少-4,358,354.22--18,155,174.09
  经营性应付项目的增加--18,912,116.41-55,008,100.98
  其他-5,266,095.85--
  债务转为资本---642,982,858.51
  现金的期末余额-155,628,331.08-159,139,572.15
  减:现金的期初余额-159,139,572.15-149,941,516.62
  现金及现金等价物的净增加额--3,511,241.07-9,198,055.53
公告日期2026-10-272026-08-252026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑